Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein I1 (FOXI1) is a member of the forkhead box (FOX) transcription factor family, characterized by a conserved forkhead DNA-binding domain. FOXI1 plays crucial roles in the development, differentiation, and function of multiple epithelial tissues, primarily by regulating the expression of genes involved in ion transport and homeostasis, such as vacuolar H⁺-ATPase subunits and SLC26A4 (pendrin). It is essential for proper cochlear, vestibular, renal, and epididymal function, and its absence or dysfunction leads to sensorineural hearing loss, balance deficits, and developmental abnormalities, such as Pendred syndrome and enlarged vestibular aqueduct. FOXI1 is also implicated in modulating chromatin structure, remaining bound to condensed chromosomes during mitosis and influencing gene accessibility. In cancer, FOXI1 shows tumor suppressive activity by activating specific signaling pathways in gastric cancer and serves as a diagnostic marker to distinguish renal tumor subtypes. No drugs are currently known to directly modify FOXI1 activity, and most clinical or pathological relevance is associated with its function or expression levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein I1 (FOXI1).